top of page
Life Sciences


Life Sciences Regulation Today
In the life sciences sector, regulation has often been perceived as a constraint: a complex web of compliance requirements slowing innovation. We believe that technology, data, and a mindset shift toward collaboration are paving the way for a regulatory ecosystem that is not only adaptive, but also enabling and transforming compliance from a back-office process into a driver of strategic value. Read to find out why Vffice turns compliance into competitive advantage.
Charlotte A.Y.
Oct 212 min read


Technological Innovations Have Transformed Traditional Healthcare Patient Monitoring Patterns with RPM
Technological Innovations Have Transformed Traditional Healthcare Patient Monitoring Patterns. The value of AI-driven healthcare technological advancements are doing more than just shortening R&D timelines, streamlining quality controls and reducing drug attrition rates. They can serve as a powerful tool for leveraging innovation in ways that drastically transform traditional healthcare monitoring practices.
Miruna E. R.
Sep 235 min read


What Erodes Trust in Biopharma?
From the standpoint of identifying the roots mistrust in biopharma, a study by Deloitte describe the industry as being profit-driven, harmful and designed to create dependency.
The above statement can be analyzed through various perspectives, as the findings uncover the key factors eroding trust in pharmaceutical companies worldwide.
In health technology, trust could be the essential ingredient that turns innovation into “real-world change”.
Miruna E. R.
Sep 93 min read


Trust as the Main Driver of Biopharma
Over the last decade, healthcare has been revolutionized by digital transformation. From streamlining administrative workflows to automating clinical documentation and live consultations, artificial intelligence drastically improved clinicians’ workloads while minimally disrupting their care delivery. With AI at the frontier of this innovation, new technologies go beyond ambient documentation.
Miruna E. R.
Sep 23 min read
bottom of page